-
Policy Matters
Public Funding is the Lifeblood of Cancer ResearchLet your voice be heard in support of robust, sustained and predictable federal funding increases.
by George D. Demetri, MD
-
The Education of a Patient AdvocateBob Riter explains how his breast cancer diagnosis set him on a path to find his calling.
by Bob Riter
-
Survivor Profile
The Bridge BuilderBreast cancer survivor Bob Riter forges connections among people affected by all types of cancer.
by Marci A. Landsmann
-
Get Involved
That Rings a BellThe End of Treatment Bells fundraiser helps patients mark milestones.
by Sophy Ziss
-
Reinforcements for Cancer ResearchScientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
-
Does Medicaid Expansion Have an Impact?Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
by Marci A. Landsmann
-
Achieving Health EqualityNational Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
by Marci A. Landsmann
-
An Uncommon PartnershipThrough the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
-
Vaccinating Against CancerThe human papillomavirus vaccine can significantly cut recipients' risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?
by Brad Jones
-
Forward Look
FDA Acts to Curb Nicotine UseEfforts focus on cigarettes and new smokeless tobacco products.
by Brad Jones
Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
Redefining Cancer SurvivorshipAs people with advanced disease live longer, they face physical and mental health side effects. Patient advocates say research and care must focus on their unique needs.
by Thomas Celona
Family of Henrietta Lacks Works for ‘Health Intelligence’Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
